The prevention and management of bleeding and thrombosis in patients with cirrhosis
poses several difficult clinical questions. These Clinical Practice Guidelines have been …

Hepatocellular carcinoma (HCC) is a major cause of death among patients with liver
cirrhosis. The rise of immuno‐oncology has revolutionized treatment for advanced HCC …

The Billroth IV consensus was developed during a consensus meeting of the Austrian
Society of Gastroenterology and Hepatology (ÖGGH) and the Austrian Society of …

Abstract Background and Objectives Iron‐deficiency anemia (IDA) is the most common form
of nutritional anemia in both developed and developing countries. We aimed to evaluate the …

Portal hypertensive gastropathy (PHG) and gastric antral vascular ectasia (GAVE) are two
distinct entities that are frequently mistaken with each other, because they present with …

Nonselective beta‐blockers are used as prophylaxis for variceal bleeding in patients with
advanced chronic liver disease (ACLD). The acute hemodynamic response to intravenous …

Abstract Introduction Portopulmonary hypertension (PoPH) carries a worse prognosis than
other forms of pulmonary arterial hypertension (PAH). Data regarding use of PAH-specific …

Background Patients with cirrhosis often develop portal hypertension-associated
splenomegaly and hypersplenism, potentially causing severe cytopenia. AIMS Systematic …

Objective Portal hypertensive gastropathy (PHG) is a common finding in patients with liver
cirrhosis (LC) and may cause both acute and chronic bleeding. A number of risk factors for …

Background Factors related to the development and severity of polycystic liver disease
(PLD) have not been well established. We aimed to evaluate the genetic and epidemiologic …